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Abstract 
Aluminium toxicity has been relatively well documented in infants with impaired renal 
function and premature neonates. 
The aims of this study were to analyse the concentration of aluminium in the majority of 
infant formulae sold commercially in Spain, to determine the influence of aluminium 
content in the tap water in reconstituted powder formulae and to estimate the theoretical 
toxic aluminium intake in comparison with the PTWI, and lastly, to discuss the possible 
interactions of certain essential trace elements added to formulation with aluminium 
according to type or main protein based infant formula. 
A total of 82 different infant formulae from 9 different manufacturers were studied. 
Sample digestion was simulated in a closed acid-decomposition microwave system. 
Aluminium concentration was determined by atomic absorption spectrophotometry with 
graphite furnace. 
In general, the infant formulae studied provide an aluminium level higher than that found 
in human milk, especially in the case of soya, preterm or hydrolysed casein-based 
formulae. 
Standard formulae provide lower aluminium intakes amounting to about 4 % PTWI. 
Specialised and preterm formulae result in moderate intake (11 – 12 % and 8 – 10 % 
PTWI, respectively). Soya formulae contribute the highest intake (15 % PTWI). 
Aluminium exposure from drinking water used for powder formula reconstitution is not 
considered a clear potential risk. 
In accordance with the present state of knowledge about aluminium toxicity, it seems 
prudent to call for continued efforts to standardise routine quality control and reduce 
aluminium levels in infant formula as well as to keep the aluminium concentration under 
300 g l-1 for all infant formulae, most specifically those formulae for premature and low 
birth neonates. 
3 
Introduction 
Aluminium is the most abundant metallic element, constituting about 8 % of 
earth’s crust. It occurs naturally under several inorganic or organic chemical forms. 
Aluminium has an omnipresent character in nature. It is found in the environment 
both as a result of natural processes and from anthropogenic sources. 
Exposure of adults to aluminium occurs through drinking water, food additives 
and antacids or buffered analgesics. However, aluminium and its compounds appear to be 
poorly absorbed and it is eliminated effectively in the urine. It has also been reported that 
neonates are more susceptible to exposure because of their greater intestinal absorption as 
a consequence of the immature gastrointestinal tract (Sedman et al.1985). 
Aluminium toxicity is associated with dementing encephalopathy, osteomalacia 
and anaemia in patients with renal failure who were receiving dialysis or oral aluminium 
containing phosphate binders. 
In infants, aluminium toxicity has been relatively well documented in the case of 
neonates with impaired renal function, and ill premature or low birth weight neonates 
(Sedman et al.1984a, b, Moreno et al. 1994, Puntis et al. 1986, Bishop et al. 1997). High 
aluminium levels in infant formulae have been implicated in aluminium intoxication in two 
infants with neonatal uraemia (Freundlich et al. 1985, 1990). 
In this respect, it is clear that infants, and especially preterm neonates, display a 
narrow tolerance to aluminium because of immaturity in the tissues and organs involved in 
its metabolism. Thus, human milk does represent the pattern of non essential elements 
most suitable for infants at term. Knowledge of the aluminium content in human milk 
serves as the basis for formulating appropriate substitutes. 
Regardless of the wide variability, the aluminium content in human milk is lower 
that that found in infant formulae, between 3 and 160 times according to data from 
bibliographical references (Koo et al. 1988, Baxter et al. 1991, Simmer et al. 1990, 
Krachler et al. 2000, Coni et al. 1990, Ballabriga et al. 1994, Fernández-Lorenzo et al. 
1999). It is thus possible to suggest a reference aluminium range of 3 - 79 g l-1 to be 
expected in human milk. Ballabriga et al. (1994) and Fernández-Lorenzo et al. (1999) 
obtained an aluminium content in Spanish human milk of 6.5 ± 5.3 g l-1 (n = 16, range 0.9 
– 19.8 g l-1) and 23.9 ± 9.6 g l-1 (n = 45, range 7 - 42 g l-1), respectively. 
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In this respect, given the evident toxicological impact of aluminium on neonates it 
is desirable that infant formulae should be proportionally similar or inferior in aluminium 
concentrations to those in human milk. 
The high aluminium content found in certain infant formulae with complex 
manufacturing processes, has led to a call for an evaluation of aluminium levels, mainly in 
both soya and preterm formulae, from international paediatric organisms (AAP 1996). 
The aims of this study were to analyse the concentration of aluminium in the 
majority of infant formulae sold commercially in Spain, to determine the influence of 
aluminium content in the tap water on final concentration in reconstituted powder 
formulae, to estimate the theoretical toxic aluminium intake in comparison with the 
Provisional Tolerable Weekly Intake (PTWI) established by the joint FAO/WHO Expert 
Committee on Food Additives (WHO 1989), and finally, to discuss the possible 
interactions of certain essential trace elements added to formulae with aluminium 
according to type or main protein based infant formula. 
Material and Methods 
Sample collection 
Infant formula 
Most infant formulae were purchased directly from manufacturers, and the rest of 
them in a distribution company in Pamplona (Spain). A total of 82 different infant 
formulae from 9 different manufacturers were studied. Formulae included both powder (n 
= 61) and ready-to-use preparations (n = 14), such as those based on cow’s milk (n = 68) 
or soy-based formulae (n = 7). Cow’s milk-based formulae included: preterm formula (n = 
7), starter formula (adapted (n = 16) and non adapted (n = 4)), follow-up formula (n = 19) 
and specialised formula (hypoallergenic (n = 12), designed for lactose intolerant (n = 7), or 
inborn errors of metabolism (n = 10) formulae). 
Infant formulae were stored in accordance with the directions on the label. 
Containers were kept in the in the absence of light at room temperature in a humidity 
controlled room. 
 
Drinking water 
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Samples of drinking water were collected in duplicate from the Community of 
Navarra (Spain) in both urban and rural areas. 
Thirty-nine tap water sampling points were selected according to a population 
census provided by the local office of the National Statistical Institute and piping 
information obtained from several public water treatment plants in the Community. 
Eighteen samples were taken from populations in rural areas and twenty one samples in 
Pamplona (capital of province). 
A strict protocol was thus established to carry out tap water sampling. 
Sample treatment 
Special care was devoted to this phase to minimise the risk of adventitious 
contamination when handling. Handling rules were adopted to minimise every possible 
source of contamination from the sampling step onwards, since any mistake in handling 
would nullify the validity of the results. 
All plastic material (low density polyethylene) or implements used which came 
into contact with the samples (infant formulae or tap water) were cleaned previously in 5 
% nitric acid solution (Merck, Darmstadt, Germany) for six days and later rinsed three 
times with ultrapure water before utilisation. 
Infant formula containers were opened in the clean laboratory under flow laminar 
bench, using vinyl talc-free gloves (Rotiprotect, Carl Roth, Karlsruhe, Germany) and 
plastic material (Plastibrand, Brand, Wertheim, Germany) to perform the sampling. 
Infant formula samples were placed in high pressure Teflon digestion bombs and 
digested with subboiling nitric acid (Merck, Darmstadt, Germany) in a closed acid-
decomposition microwave system (Milestone MLS 1200, Millestone s.r.l., Sorisole, Italy). 
The solutions obtained were then diluted with ultrapure deionised water and kept 
in frozen storage at -20 ºC until analysis. Samples were digested in triplicate. Sampling 
and treatment operations have been described previously in greater detail (Navarro and 
Alvarez 2002). 
In the case of drinking water samples, to avoid flocculation or losses by 
adsorption to the plastic walls in sampling containers always after measuring pH, 1 mL of 
subboiling nitric acid per litre was added until approximately pH = 2, and the solution was 
stored at 4 ºC until analysis. 
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Analytical methods 
Aluminium concentration was determined by graphite furnace atomic absorption 
spectrometry (GFAAS, GBC GF 2000, Dandenong, Victoria, Australia). The operating 
parameters and optimising temperature program of the instrument are given in table 1. 
[Insert table 1 about here] 
Digested samples were diluted in matrix modifier solution. Injections (20 L) 
were made in triplicate on L’vov platforms positioned inside pyrolytically coated tubes. 
Samples were quantified by reference to a calibration curve obtained for aqueous 
standards. Working standard solutions (0 to 80 g l-1) were made up each day by dilution 
from stock 1000 mg l-1 standard solution (Merck, Darmstadt, Germany) in enough 
subboiling nitric acid to a final acid concentration similar to prepared samples. All 
solutions were kept in the covered carousel throughout the analyses to prevent any 
contamination. 
Two blanks reagents, an aqueous internal standard, and a replicate of infant 
formula control, as well as ten infant formula samples were included in each analytical 
batch to provide on-going quality control information. 
The results of the quality control program, repeatability (precision for triplicates 
with a run) and reproducibility (day to day precision), expressed as coefficient of variation, 
are presented in table 2. 
[Insert table 2 about here] 
Analytical blanks were used to correct for any possible contamination during 
analysis. When expressed in terms of infant formula, aluminium content was 2.3 ± 0.3 g l-
1. The detection limit was defined as the average of three times the standard deviation of 
the reagent blanks and corresponded to 3.3 g l-1 (wet weight) for the infant formulae. In 
the case of drinking water, blank reagents consisted of ultrapure water which was 
subjected to the same procedures of treatment, storing and mixing with matrix modifier. 
Aluminium level in analytical blanks was 0.2 ± 0.5 g l-1, resulting in a detection limit of 
1.7 g l-1. 
Reference infant formulae were run throughout the course of the study (174.8 ± 
4.2 g l-1). The control sample was previously analysed by the standard addition 
calibration to minimise matrix effects and an aluminium value of 176 ± 7 g l-1 was 
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obtained. Recovery assays of spiked aluminium at different concentrations in this in-house 
control formula were satisfactory, ranging from 96 to 104 %. 
An internal aqueous quality control (20 g l-1) was run concurrently with 
analytical samples. The mean ± s.d. of aluminium determined was 20.0 ± 1.1 g l-1 (n = 
34), with a range of 18.2 – 22.3. The acceptable range established in the quality program 
was 17.6 – 22.4 g l-1. 
Given the unavailability of adequate reference material based on milk powder 
with certified values, IAEA (International Atomic Energy Agency) 155 whey powder was 
analysed to provide an estimate of accuracy and to guard against instrument bias. The 
obtained result (43.2 ± 2.6 mg kg-1) shows an acceptable agreement with the information 
value (non certified) provided from the reference material (53 mg kg-1, ranged 38 – 68). 
Iron and zinc concentrations in digested acid solutions were analysed by flame 
atomic absorption spectrophotometry (FAAS, GBC GF 2000, Dandenong, Victoria, 
Australia) and inductively coupled plasma atomic emission spectrometry with Meinhard 
nebulizer (ICP-AES, Jobin Ybon JY 38S Plus Sequential) was used for manganese. 
Iron, zinc and manganese calibration curves were accomplished using direct 
calibration against aqueous standards. Details of measurements, operating parameters and 
trace element quantification have been described elsewhere (Navarro et al. 1996, Navarro 
et al. 2000). 
The IAEA milk powder A11 was assayed as standard reference material to 
validate the analytical method. Standard A11 was mineralised and analysed as stated above 
for infant formulae. The values determined (12 independent analytical runs) were: iron, 
3.62 ± 0.09 g g-1; zinc, 37.10 ± 0.38 g g-1 and manganese, 0.250 ± 0.021 g g-1; in 
comparison with certified values (confidence intervals): iron, 3.65 g g-1 (2.89 – 4.41); 
zinc, 38.9 g g-1 (36.6 – 41.2) and manganese 0.257 g g-1 (0.248 – 0.266). 
Chemicals 
Suprapure nitric acid was purchased from Merck (Merck, Darmstadt, Germany) 
and distilled by subboiling before use. 
Ultrapure deionised water type Milli Q was used for preparation and/or dilution of 
treated sample and standard solutions. 
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Magnesium nitrate was used as matrix modifier for aluminium determination (1,4 
g of Mg(NO3)2.6H20 (Merck, Darmstadt, Germany) and 2 ml of Triton X-100 (Sigma, St. 
Louis, USA) were diluted in 1 L with ultrapure water). 
Statistical Analysis 
Statistical analysis was performed with SPSS v.9.0 for windows. Different groups 
of samples were compared through non parametric Kruskal-Wallis and Mann Whitney U-
tests or Wilcoxon test for paired groups, with statistical significance set at p < 0.05; and 
observed tendencies in some trace element contents with regard to aluminium were 
analysed with the Spearman coefficient. 
 
Results and Discussion 
Aluminium contents in infant formula 
Table 3 shows the aluminium concentrations for each of the types of infant 
formulae studied. Aluminium concentration found in powdered infant formula was 
calculated according to the manufacturer’s dilution instructions to express the content in 
g l-1. 
[Insert table 3 about here] 
The wide variability in aluminium content found in some of the formulations 
included in this study is of special relevance. Because of this, both mean and median 
values were included in the results table, although we have only used the median value as 
the most representative parameter. 
In this sense, the range of aluminium determined in analysed formulae reflects 
findings reported in the literature by several researchers listed in table 4. 
[Insert table 4 about here] 
This notorious variability is a result of the way aluminium is incorporated in 
infant formulae. Obviously the total aluminium content comes from: a) the source of raw 
material, that is cow’s milk or isolated soy protein; b) it could be included during 
processing from metallic surfaces of equipment or utensils; c) it could be contributed by 
the additives or mineral supplements added, and lastly, d) it might be transferred from the 
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container during storage. Each of these factors could explain by itself the high variability 
in the aluminium concentrations found in the different infant formulae studied.  
In a first view of aluminium levels in different types of infant formula, it is easy to 
observe the lower aluminium values determined in standard formulae (starter and follow-
up formulae) in comparison with specialised, preterm and soya formulae. Subsequently, 
this fact was verified by the Kruskal-Wallis test (p = 0.003). 
As previous studies have reported (Koo et al. 1988, Baxter et al. 1991, Simmer et 
al. 1990, Ballabriga et al. 1994, Bloodworth et al. 1991, Ikem et al. 2002, Dabeka and 
Mckenzie 1990), the lower aluminium values were detected in milk based formulae, to be 
more specific in this study, in starter formulae (adapted, 196 ± 152 g l-1 and non adapted 
231 ± 128 g l-1) and follow-up formulae (272 ± 189 g l-1). These levels are in agreement 
with those found by other American and European researchers (Ballabriga et al. 1994, 
Fernández-Lorenzo et al. 1999, Hawkins et al. 1994, Coni et al. 1993, Ikem et al. 2002). 
Lower levels found in raw cow’s milk show that this by itself is not necessarily the 
greatest source of aluminium. However, large aluminium ranges observed in standard 
formulae are indicative of the potential for contamination during manufacture. 
It is well known that aluminium is associated with proteins. Table 5 summarises 
aluminium levels found in different infant formulae, focusing on the main protein 
contained. 
[Insert table 5 about here] 
In this respect, there is clear evidence about the involvement of intrinsic 
aluminium coming from a protein source on the final level found in standard formulae. The 
highest aluminium content is provided by those formulae based on whole milk (adapted 
starter formulae: 338 ± 114 g l-1, non adapted starter formulae: 368 g l-1 and follow-up 
formulae: 296 ± 185 g l-1), followed by skim-milk-based formulae (adapted starter 
formulae: 190 ± 83 g l-1, non adapted starter formulae: 136 ± 115 g l-1 and follow-up 
formulae: 223 ± 220 g l-1) and lastly, formulae that include whey proteins (adapted starter 
formulae: 181 ± 177 g l-1) or casein (adapted starter formulae: 126 ± 38 g l-1) in its 
composition (Table 5). 
The present tendency to reduce the protein content, and to replace different 
proteins with whey protein to be rather like the protein profile found in human milk, may 
determine the aluminium content in infant formula, which is advantageous in this respect, 
in the newer formulations. 
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Nevertheless, the complex manufacturing process of specialised formulae seems 
to play an important role in the degree of aluminium contamination. The highest 
aluminium value was determined in formulae designed for inborn errors of metabolism 
(443 ± 112 g l-1), an intermediate level was found for formulae without lactose (399 ± 
451 g l-1) and finally, the lowest content was supplied for hypoallergenic formulae (294 ± 
945 g l-1). 
The probable source of aluminium contamination might be mainly a consequence 
of the formula ingredients added (calcium and phosphate salts, vitamins and other 
minerals) and in second place, the complex processing in which infant formulae come into 
contact with aluminium-containing surfaces and equipment for the long time that their 
preparation requires. 
A large amount of aluminium in formulae designed for diverse pathologies is an 
additional source of aluminium for infants fed on these. Although this is unclear, it may 
represent a health hazard for this risk group of infants. Among the formulae without 
lactose, mainly casein-based formulae, one formula with a high aluminium level bring out 
(1439 g l-1). Similarly, there were two hypoallergenic formulae with aluminium values of 
2649 and 2720 g l-1, both based on hydrolysed protein (casein hydrolysate) and from the 
same manufacturer (Figure 1). 
[Insert figure 1 about here] 
If table 5 is carefully observed, it is possible to see that aluminium content in 
casein hydrolysed hypoallergenic formulae (654 ± 1233 g l-1) is significantly higher (p = 
0,015, Mann Whitney U test) than in whey hydrolysed hypoallergenic formulae (190 ± 110 
g l-1). These contents are explained by the necessity for aggressive treatment in order to 
modify highly the raw material which means that formulae may be exposed to a significant 
amount of aluminium during manufacture from the chemicals used, machinery and dust 
particles. 
Specialised formulae also contain greater quantities of substances such as 
calcium, iron, and citrate complexes that may enhance aluminium absorption from the 
gastrointestinal tract by unknown mechanisms (Sahin et al. 1995). Thus, it is reasonable to 
understand both the increased bioavailability of aluminium and the elevated plasma 
concentration noted in the infants fed on casein hydrolysed formulae (Hawkins et al. 
1994). These may turn out to be recognised risk factors that must be taken into 
consideration. 
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Aluminium content in premature formulae (421 ± 137 g l-1) is significantly 
higher than that determined in formulae for infants at term (non adapted starter, p = 0.042 
and adapted starter, p = 0.010). This tendency has been supported by many researchers 
who provide a similar range of aluminium concentrations (Ballabriga et al. 1994, Hawkins 
et al. 1994, Coni et al. 1993, Plessi et al. 1997). They try to explain these high levels as a 
consequence of the type of processing or food additives used which contain aluminium. 
Aluminium toxicity and the potential impact of these formulae on premature infants’ 
health is one of the main concerns of international paediatric organisations (WHO 1989). 
To date, preterm infant formulae are regarded as a potential source of aluminium 
exposure. The risk of aluminium accumulating in these formulae may be raised especially 
in preterm infants with renal immaturity linked to a low aluminium clearance due to 
decreased urine excretion (Sedman et al. 1984b). Moreover, the hypothesis that aluminium 
overload may be due to an increased intestinal absorption during the first weeks of neonate 
life has been reported. Both increased absorption and low excretion could explain the high 
plasma values observed in healthy premature and low birth weight newborns (Sedman et 
al. 1984b, Puntis et al. 1986, Stockhausen et al. 1990). 
Aluminium absorption in infancy has been investigated in a previous study on 
antacids (Chedid et al. 1991), and the risk of toxicity as a result of exposure to drugs 
containing aluminium or aluminium contamination of infant formulae has been confirmed. 
In addition, adverse effects on bone mineralization associated with high plasma aluminium 
levels in infants have been reported (Bougle et al. 1997). Although direct inhibiting effects 
of aluminium on bone mineralization have not fully been explained, they seem to be a 
consequence of interactions with both calcium and phosphorus enhanced by the high 
aluminium content in premature formulae. 
In spite of this, in view of our present knowledge and taking into account the 
nutritional benefits of premature formulae, it is necessary to keep up to date with these 
formulations and request from manufacturers the need for a total restructuring of older 
production processes in order to achieve a further reduction in the aluminium levels in this 
kind of infant formula. 
Concentrations of aluminium in the soya formulae ranged from 313 – 3479 g l-1, 
median (573 ± 1132 g l-1). Undoubtedly, these formulae provide the highest aluminium 
levels of all studied formulae and as table 3 reveals, the aluminium content is significantly 
higher than in standard formulae (adapted formulae, p = 0.001; non adapted formulae, p = 
0.024 and follow-up formulae, p = 0.004). High levels have also been reported by other 
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studies (Table 4), calling into question the nutritional safety of soya formulae for neonate 
feeding. 
Aluminium is naturally present in soy beans, and aluminium impurities which are 
contained in other basic components of the soya formulae or caused by contamination 
during manufacture represent the most probable reasons for such high aluminium levels in 
soya formulae. 
Regarding the manufacture of soya formulae, its preparation requires crushing, 
refining and washing procedures to isolate the soy protein from soya bean. A strong 
treatment with calcium hydroxide, which often contains high amount of aluminium as an 
impurity, is carried out. 
It therefore seems likely that an important part of the final aluminium 
concentration in soya formulae may be attributed to adventitious contamination during the 
isolation more than the intrinsic aluminium content of soya beans. 
Among the soya formulae, we detected one formula with a very high aluminium 
value (3479 g l-1) with respect to other infant formulae. This aluminium level is not 
surprising if we compare it with values determined in other national or international 
studies, where similar ranges are found or even several formulae have a higher aluminium 
concentration of anything up to 5076 g l-1 (Woollard et al. 1990). 
In order to know the influence of the aggregation state on the amount of 
aluminium found in infant formula, we evaluated statistically the aluminium contents in 
both powder and ready-to-use liquid formulae. 
The industrial production process of milk-based powder formulae involves several 
operations (warming, centrifugation, drying, homogenising, bleeding, sterilisation, 
packing, etc.), which bring it into contact it with metallic surfaces of industrial machinery. 
In the case of ready-to-use formulae, processing is quite different. From the 
perspective of this study, the critical process for liquid formulae is the treatment in cationic 
interchange columns, besides the addition of vitamins or mineral salts. 
Considering the 14 pairs of infant formulae with both commercially available 
formulae (powder and liquid forms), the aluminium content did not differ significantly (p = 
0.060, Wilcoxon’s test) between powder and liquid data groups, although the aluminium 
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content in ready-to-use formulae had a tendency to be lower than in powder formulae, as in 
recent studies (Ikem et al. 2002) and in contrast to earlier findings (Gruskin 1991). 
Aluminium levels for both powder and liquid formulae over the different types of 
infant formulae are summarised in table 6. At first glance, the difference found in 
aluminium could be surprising but we must keep in mind the fact that liquid formulae 
started to be sold in Spain during the past decade, and were manufactured with a more 
novel and, in principle, purified process of handling and preparation, in contrast to older 
powder infant formulae. 
[Insert table6 about here] 
 
Manufacturer and determined values 
In general, the manufacturing process has been described as an important source 
of exogenous aluminium contamination. 
It is obvious that commercial brands do not include any value for aluminium in 
the information label. Nevertheless, it is to be expected that this metal should be included 
in the quality control program and manufacturers should try to obtain the lowest 
aluminium concentration in infant formula as far as possible. 
In order to compare, figure 1 shows concentrations of aluminium determined in 
the different infant formula belonging to the nine manufacturers evaluated. 
The meticulous care shown by manufacturers 7 and 2 (150 ± 90 g l-1, n = 5 y 142 
± 929 g l-1, n = 14, respectively) is curious, while manufacturers 3 and 6 (436 ± 67 g l-1, 
n = 7 y 416 ± 126 g l-1, n = 8) show quite the opposite with a large range of aluminium 
concentration (338 – 541 g l-1 y 261 – 573 g l-1, respectively). It is also necessary to 
mention manufacturer 8 which includes numerous (n = 16) and complex formulations in its 
stock with a discrete aluminium contribution from prepared infant formulae. 
When the different infant formulae were considered as a whole, median 
aluminium content was 340 g l-1 (where percentiles 25 and 75 were 177 and 478 g l-1, 
respectively). However, seen separately median aluminium values of different commercial 
households ranged from 142 to 436 g l-1. 
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Considering both points, it would not be imprudent to recommend an upper limit 
to be set in infant formulae around 300 – 400 g l-1, which manufacturers could take on 
without excessive economic cost. 
In view of these results and taking into consideration the program to reduce the 
level of aluminium in infant formula launched by the manufacturing industry in other 
European countries (Baxter et al. 1991), it seems suitable to call for an effort a) to control 
as far as possible the critical points of aluminium contamination, b) to modify the 
industrial handling process in order to obtain formulations in which the concentration of 
aluminium is less than 300 g l-1 in premature and standard formulae, and 400 g l-1 in the 
other formulae, a criterion which is a little more restrictive than the recommendation 
suggested by Simmer et al. (1990), and c) to analyse frequently or routinely the aluminium 
contents, especially in those formulae with potential impact such as premature or soya 
formulae. 
 
Estimated dietary aluminium intake 
The possibility that aluminium could cause health problems in infants justifies the 
comparison of estimated dietary intake provided by infant formulae studied with the 
Provisional Tolerable Weekly Intake (PTWI, 7 µg kg-1 of weigh) established by the Joint 
FAO/WHO Expert Committee on Food Additives (WHO 1989). 
Considering that the newborn in each age period observes a similar feeding 
regimen, in comparison with the PTWI, we have worked out a weekly aluminium intake 
for infants fed on different types of infant formulae, observing separately the special case 
of preterm newborns. The daily intake of formulae is estimated according to recommended 
doses and the feeding tables specified by the manufacturers. 
Table 7 shows the daily amount of aluminium supplied by different infant 
formulae. 
[Insert table 7 about here] 
Dietary aluminium intake estimated by Dabeka and Mckenzie (1990) through 
human milk was 2 µg day-1 and 3 µg day-1 for Canadian infants 0 – 1 and 1 – 3 months old, 
respectively. If we estimate a human milk reference value from published levels (3 – 79 µg 
l-1), assuming a daily milk intake of 200 ml kg-1, the range determined implies a daily 
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aluminium intake of 2.4 – 63.2 µg day-1 (0.6 – 15.8 µg kg-1 day-1), slightly higher than 
previous estimated intakes. 
The great difference observed in comparison with the aluminium supply from 
human milk is well known. This fact explains the special interest aroused in Paediatric 
organisations in reducing the aluminium content in artificial feeding for infants. 
Figure 2 compares weekly the aluminium intake (percentage of the PTWI) 
estimated for each type of infant formulae studied. The differences between standard 
formulae and soya or specialised formulae observed before, are reflected clearly. 
[Insert figure 2 about here] 
Starter and follow-up formulae provide the lowest aluminium intake, about 4 % of 
the PTWI. Specialised formulae, with hypoallergenic formulae in the first place, yield an 
intermediate intake (11 – 12% of the PTWI). Finally, soya formulae contribute the highest 
intake (15 % of the PTWI). 
Preterm intakes were calculated taking into account the paediatric specifications 
or manufacturers guidelines and infant weight. Figure 3 contains the estimated weekly 
aluminium intake by infants fed on preterm formulae. 
[Insert figure 3 about here] 
These formulae provide a toxic intake similar to special formulae, around 8 – 10 
%. This PTWI percentage is far from that supplied by Spanish human milk (0.1 %) and the 
theoretical value found with the upper limit human milk reference (1.3 %). Once again, the 
need is highlighted to monitor aluminium contents in this kind of infant formula, because 
of the risk of developing aluminium toxicity, with the only objective of obtaining a 
maximum aluminium level similar to the upper limit for human milk. Further studies are 
therefore required to ensure the safety of formulae for preterm and low weight infants. 
Finally, it is possible to evaluate the hypothetical case of an infant formula 
exceeding the aluminium limit to find the PTWI. This formula should contain an 
aluminium level ranging from 6000 – 8000 g l-1. None of the formulae analysed provides 
more than this interval of values. 
If we consider the highest aluminium level determined in the infant formulae 
analysed (3479 g l-1, soya formula), daily aluminium intakes would be approximately 45 
– 55 % of PTWI. 
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In spite of everything, it is necessary to be prudent when establishing permissible 
aluminium intakes, since the absolute calculations must be taken as an approximate 
estimate, although they are certainly useful to evaluate and make a conservative 
recommendation about aluminium content in infant formulae. 
 
Complementary contribution to daily aluminium intake from drinking water 
Aluminium concentration in natural waters varies significantly depending on 
numerous physicochemical, mineralogical and geochemical factors. 
Water treatment in purifying plants includes a coagulation process using 
aluminium sulphate to remove organic matter. The beneficial effect of the use of this metal 
in treated water is recognised. Nevertheless, in spite of good operating conditions, a 
residual amount is retained and supplied in drinking water. European Community 
legislation (Directive 80/778/EEC) and WHO guidelines have established an acceptable 
aluminium concentration of 200 g l-1 in drinking water (Commission of the European 
Communities 1980, WHO 1998). 
This authorised aluminium level is similar to that found in standard infant 
formula. As a consequence, it is interesting to evaluate aluminium exposure from tap water 
and its relative contribution to dietary intake of infants fed on reconstituted powder 
formulae. 
In accordance with the legislation currently in force, taking into consideration the 
marked daily intake of newborns, tap water used in prepared formulae could supply similar 
aluminium amounts to those provided by infant formulae on their own.  
Aluminium content determined is 22.6 ± 4.5 g l-1 (range 4.5 – 172.4 g l-1). 
There is no significant difference between aluminium levels found in rural (24.2 ± 9.3 g l-
1) and urban groups (22.3 ± 2.2 g l-1). The mean aluminium value was used to establish 
the influence of aluminium content in drinking water on the final concentration of 
reconstituted infant formulae. 
The amount provided by tap water used in reconstitution of premature formulae is 
similar to the lower limit found in human milk, approximately 0.05 – 0.06 % of the ISTP. 
At the same time, aluminium supply to another infant formulae, is also low, about 10 % of 
standard formulae and 2 – 3 % of special and soya formulae (table 7). 
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Our results indicate that aluminium exposure from tap water used for formula 
preparation is not a clear potential risk. Although it is necessary to know that aluminium 
concentration in drinking water can vary significantly depending on the geographic and 
geochemical medium where the water supply or spring are sited. 
 
Interactions between aluminium and other trace elements 
The levels of trace elements in infant formulae are generally higher than in human 
milk. In recent years, considerable changes in the levels of these elements in infant 
formulae have been instituted in the light of improved knowledge of infant requirements. 
Trace elements normally added to the raw material (cow milk or soy) are supplied 
in an inorganic form, sometimes in a high level to compensate for the lower bioavailability 
of infant formulae (Brätter 1996). There is little information on the impact of these 
changes and added elements on the final concentration of potential toxic trace elements, 
including aluminium. 
In order to observe the tendency in the levels of certain essential trace elements in 
relation to the aluminium level in infant formulae, since some toxic metals and 
nutritionally essential elements share common chemical characteristics, a comparative 
statistical analysis using the Spearman coefficient between the aluminium and different 
trace element contents was carried out. 
Aluminium behaves similarly to iron in many biological systems (Goyer 1997). 
As can be observed in figure 4, an inverse correlation was established for follow-up 
formulae between both concentration values (p = 0.044). Cow milk is a very poor source 
of iron. 14 % of iron occurs in milk fat, about 24 % is bound to casein, while 29 % is 
bound to whey protein and 32 % is associated with a low molecular weight fraction 
(Fransson and Lonnerdal 1983). The studied follow-up formulae are mainly based on skim 
and whole cow milk. This interaction could be attributed to the lower amount of iron added 
to whole-milk-based formulae, which is linked to a higher aluminium content as was 
discussed above. On the other hand, for those follow-up formulae based on skim-milk, the 
iron supplementation to find the requirement is most important but the manufacturing 
process is simpler. 
[Insert figure 4 about here] 
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Furthermore, the distribution of iron added to infant formula depends on the 
chemical form of iron supplement used. Supplementation with Fe (II) results in a formula 
with high iron content in the fat fraction (Hegenauer et al. 1979) whereas if Fe(III) is used, 
the iron is bound to casein micelles (Demott and Dincer, 1976). Probably, the existing 
correlation in whole-milk-based formulae (p = 0.010) could correspond with the different 
chemical form used in iron supplementation and the technological process used by 
manufacturers. The same consideration might be established for formulae designed for 
inborn errors of metabolism (p = 0.013), although the complexity in formulations included 
in these groups does not allow a clear explanation. 
Another negative correlation (p = 0.004) was found between zinc and aluminium 
concentrations in standard infant formulae (figure 5). This corresponds to changes in 
protein profile by manufacturers, since as in cow milk most of the zinc is in the skim milk 
fraction and 95 % is associated with casein micelles (Blakeborough et al. 1983, Sing et al. 
1989). Lower aluminium and higher zinc concentration were found in casein-based 
formulae, followed by intermediate values of both elements in whey and skim-milk-based 
formulae and finally, whole-milk-based formulae provide the highest aluminium and 
lowest zinc added concentrations. This same tendency is observed for starter and follow-up 
formulae by themselves with a statistical significance correlation p = 0.004 and p = 0.030, 
respectively. 
[Insert figure 5 about here] 
Finally, a positive correlation was established in hypoallergenic formulae between 
manganese and aluminium contents (p = 0.006). Manganese is distributed in cow milk, 67 
% binding to casein, 18 % to low molecular weight proteins and 1 % to lipid fraction 
(Lonnerdal et al. 1985). This fits with both higher aluminium and manganese contents 
found in hydrolysed-casein-based formulae and lower values of these elements in 
hydrolysed-whey-based formulae. 
 
Conclusions 
Commercial infant formulae should provide an efficient alternative to human 
milk, providing a nutritional source that is safe and adequate to neonate needs when the 
human milk supply is not possible or is insufficient. 
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In this regard, human milk is still the reference for micronutrients and non-
essential trace element contents, given that these data may not be obtained from healthy 
neonates for ethical reasons. 
According to our results, the infant formulae studied provide an aluminium level 
that is higher than that found in human milk, especially those formulae of high 
technological complexity (premature, specialised and soya formulae). 
International paediatric organisations (AAP 1996) request from manufacturers 
continued efforts to reduce the aluminium level in infant formulae, bearing in mind mainly 
soya and preterm formulae. In this sense, specialised formulae based on hydrolysed protein 
like casein must be incorporated in the risk formulae group, due to their high aluminium 
content. 
High aluminium infant formulae should be evaluated by manufacturers, who 
should routinely monitor aluminium concentrations, especially in those formulations 
prepared to feed premature or low birth neonates. 
In accordance with the present state of knowledge about aluminium toxicity, it is 
appropiate to set a maximum guide value for infant formula at 300 g l-1. Firstly, this level 
is possible for manufacturers, and in second place, a recent study (Hawkins et al. 1994) 
indicated that most infants who consumed infant formulae containing more than this limit, 
had a raised plasma aluminium concentration and so may be at risk of aluminium toxicity. 
For these reasons, the safe and adequate aluminium level in infant formulae 
requires further study. Speciation studies are required in order to establish and characterise 
the chemical forms in which aluminium is present in human milk and infant formulae 
(Brätter et al. 1998), with the goal of determining the real toxicity of aluminium 
compounds and evaluating the true risk of feeding neonates on infant formulae. 
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Table 1. Instrumental parameters and optimising furnace program for aluminium 
determination. 
 
Instrumental parameters 
Wavelength (nm) 
Slit width (nm) 
Lamp current (mA) 
Sample volume (L) 
Measurement Mode 
Source 
Background correction 
309.3 
1.0 
10 
20 
Peak area 
Hollow cathode lamp 
Deuterium lamp 
Temperature program 
Step Temperature (ºC) 
Ramp 
(s) 
Hold 
(s) 
Argon flow 
(ml min-1) Read on 
Drying 1 110 5 15 300 - 
Drying 2 250 10 15 300 - 
Charring 1500 20 5 300 - 
Atomization 2500 1 4 300 - 
Cleaning 2600 1 5 0 Yes 
Cooling 20 5 3 300 - 
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Table 2. Results of quality control program for aluminium analysis in infant formulae. 
 
Quality program n Mean ± SD 
(µg l-1) 
Repeatability 
(%) 
Reproducibility
(%) 
Blank reagents 
Infant formulae 
Drinking water 
 
34 
8 
 
2.3 ± 0.3 
0.2 ± 0.5 
 
13.9 
- 
 
15.5 
- 
Internal Standard* 34 20.0 ± 1.1 1.6 2.6 
Infant formula Control# 34 174.8 ± 4.2 2.4 2.7 
Recovery assay (%) 
Infant formula Control 
 
34 
 
96 –104 
  
Detection limit (µg l-1)¶ 
Infant formulae 
Drinking water 
 
34 
8 
 
3.3 
1.7 
  
IAEA 155 Whey powder (mg kg-1)
Determined level  
Information level 
 
12 
 
43.2 ± 2.6 
53 (38-68) 
  
* Aqueous internal standard: 20 µg l-1 
# Infant formula control: 176 ± 7 (analysed by standard addition method) 
¶ Calculated as Mb ± 3 s.d.b (Mb: blank mean, s.d.b: standard deviation of blank) 
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Table 3. Aluminium content in different types of studied infant formulae (µg l-1). 
 
Infant formula n Mean Median ± SD Range 
Preterm Formula 7 449 421 ± 137 317 – 726 
Starter Formula 
- Non adapted 
- Adapted 
 
4 
16 
 
237 
252 
 
231 ± 128 
196 ± 152 
 
118 – 368 
68 – 573 
Follow-up Formula 19 292 272 ± 189 66 – 788 
Specialised Formula 
- Without lactose Formula 
- Hypoallergenic Formula 
- Inborn errors diet 
 
7 
12 
10 
 
574 
687 
453 
 
399 ± 451 
294 ± 945 
443 ± 112 
 
102 – 1439 
105 – 2720 
307 – 655 
Soya Formula 7 930 573 ± 1132 313 – 3479 
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Table 4. Aluminium content in infant formulae from different countries. 
 
Reference Country Aluminum (g l-1) Formula 
n Mean Median Range  
Bloodworth et al., 
1991. (19) 
Singapore 25 
4 
  40 - 370 
470 - 2500 
Cow’s milk-based 
Soy-based 
Simmer et al., 
1990 (11) 
Australia 17 
4 
7 
4 
  72 - 1463 
184 - 1106 
62 - 939 
1192 - 1711 
Starter and follow-up 
Preterm 
Specialized 
Soy-based 
Ballabriga et al., 
1989 (14) 
Spain 79 
16 
26 
13 
10 
  202 ± 111* 
322 ± 164* 
530 ± 412* 
542 ±178* 
805 ± 217* 
Adapted 
Preterm 
Hypoallergenic 
Without lactose 
Soy-based 
Fdez-Lorenzo et 
al., 1999 (15) 
Spain 47 
17 
218.6
245.8
160 
130 
8 - 1149 
18 - 1129 
Starter 
Follow-up 
Biego et al., 1991 
(20) 
France 6   68 ± 19 - 
Baxter et al., 1991 
(10) 
UK 14 
7 
  40 - 200 
640 - 1340 
Cow’s milk-based 
Soy-based 
Hawkins et al., 
1994 (21) 
UK 24 
7 
14 
7 
7 
165 
300 
161 
773 
534 
 151 - 180 
272 - 328 
143 - 180 
632 - 914 
470 - 598 
Starter 
Preterm 
Fortified 
Hypoallergenic 
Soy-based 
Coni et al., 1993 
(22) 
Italy 12 
4 
5 
5 
8 
  50 - 260 
80 - 410 
110 - 600 
390 - 1010 
30 - 850 
Starter 
Preterm 
Specialized 
Soy-based 
Ready-to-use 
Plesi et al., 1997 
(23) 
Italy 1 
1 
1 
1 
1 
1 
1 
  450 ± 117* 
479 ± 93* 
463 ± 180* 
2285 ± 232* 
1791 ± 275* 
1057 ±51* 
913 ± 171* 
Starter 
Follow-up 
Preterm 
Hypoallergenic 
Hypoallergenic 
Soy-based 
Soy-based 
Sahin et al., 1995 
(24) 
Turkey 10   163 - 1475* - 
Ikem et al., 2001 
(25) 
Nigeria 
UK 
 
USA 
6 
12 
18 
9 
6 
  58 ± 22 
92 ± 85 
101 ± 37 
150 ± 120 
460 ± 160 
Adapted (powder) 
Adapted (powder) 
Adapted (liquid) 
Adapted (powder) 
Soy-based (powder) 
28 
Koo et al., 1988 
(9) 
USA - 
 
  0.014 - 0.453**
0.60 - 2.3** 
15 - 108* 
342 - 1377* 
Cow’s milk-based (liquid) 
Soy-based (liquid) 
Cow’s milk-based (powder)
Soy-based (powder) 
Dabeka and 
Mckenzie, 1990 
(26) 
Canada 6 
4 
9 
7 
9 
4 
0.13 
1.98 
97 
1274
0.22 
1.41 
0.091
0.84 
68 
1126 
0.18 
1.21 
0.010 - 0.36** 
0.40-6.4** 
26-336* 
425-2430* 
0.017-0.56** 
0.59-2.29** 
Cow’s milk-based (liquid) 
Soy-based (liquid) 
Cow’s milk-based (powder)
Soy-based (powder) 
Cow’s milk-based (conc.) 
Soy-based (concentrated) 
Woolard et al., 
1991 (27) 
Various 
countries 
307
55 
189 
2484
 22-519* 
1404-5076* 
Cow’s milk-based 
Soy-based 
*Recalculated aluminium concentration (according to dilution 13.5 %) and expressed in µg l-1 
** Expressed by authors “as sold” basis in g g-1 
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Table 5. Aluminium concentrations in different types of infant formulae with regard to the 
main protein contained (µg l-1). 
 
Infant formula Aluminium 
 n Median ± SD Range 
Preterm Formula 
Whey-based 
Skim-milk-based 
Whole-milk-based 
Casein hydrolysed 
 
4 
1 
1 
1 
 
402 ± 43 
726 
436 
317 
 
339 – 421 
– 
– 
– 
Starter Formula 
- Non adapted 
Skim-milk-based 
Whole-milk-based 
- Adapted 
Whey-based 
Casein-based 
Skim-milk-based 
Whole-milk-based 
 
 
3 
1 
 
6 
3 
2 
5 
 
 
136 ± 115 
368 
 
181 ± 177 
126 ± 38 
190 ± 83 
338 ± 114 
 
 
118 – 325 
– 
 
158 – 573 
68 – 139 
132 – 249 
261 – 541 
Follow-up Formula 
Whey-based 
Skim-milk-based 
Whole-milk-based 
 
1 
13 
5 
 
334 
223 ± 220 
296 ± 185 
 
– 
66 – 788 
121 – 459 
Specialised Formula 
- Without lactose Formula 
Casein-based 
Skim-milk-based 
- Hypoallergenic Formula 
Whey hydrolysed 
Casein hydrolysed 
- Inborn errors diet 
Casein-based 
Skim-milk-based 
Whey hydrolysed 
Casein hydrolysed 
Free aminoacids 
No protein 
 
 
6 
1 
 
7 
5 
 
1 
1 
1 
4 
2 
1 
 
 
460 ± 439 
102 
 
190 ± 110 
654 ± 1233 
 
307 
518 
655 
449 ± 98 
401 ± 51 
370 
 
 
309 – 1439 
– 
 
105 – 412 
298 – 2720 
 
– 
– 
– 
335 – 529 
364 – 438 
- 
Soya Formula 
Soy-based 
 
7 
 
573 ± 1132 
 
313 – 3479 
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Table 6. Aluminium levels (µg l-1) from different types of infant formulae studied attending 
to aggregation state (powder or liquid formulae). 
 
Formula Powder Ready-to-use 
 n Mean Median Range n Mean Median Range 
Preterm Formula 6 467 428 ± 20 317 – 726 1 340 – – 
Starter Formula         
Non adapted 3 271 325 ± 18 118 – 368 1 140 – – 
Adapted 12 273 215 ± 26 130 – 573 4 187 172 ± 14 68 – 340 
Follow-up Formula 13 313 340 ± 46 66 – 788 6 245 223 ± 14 150 – 460
Specialised Formula         
Hypoallergenic 10 784 338 ± 1014 120 – 2720 2 201 201 ± 19 105 – 300
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Table 7. Daily intakes of aluminium for infants fed on infant formulae and drinking water 
used in the reconstitution of powder formulae (µg day-1). 
 
Age 
Starter Formula Follow-up Specialised Formula Soya  Drinking 
Non 
adapted Adapted 
Formula Without 
lactose HA 
Inborn 
errors 
diet 
Formula water 
0 - 2 weeks 148 155 - 387 510 381 538 12.2 
3 - 4 weeks 188 203 - 516 608 508 731 16.2 
2 month 238 244 - 597 754 574 798 20.3 
3 month 238 264 - 654 778 680 915 20.3 
4 - 5 month 283 295 - 761 986 785 1055 23.7 
6 month 257 302 296 793 854 846 1133 14.2 
> 7 month - - 249 - - - - 10.8 
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Manufacturer 9
Manufacturer 8
Manufacturer 7
Manufacturer 6
Manufacturer 5
Manufacturer 4
Manufacturer 3
Manufacturer 2
Manufacturer 1
Al (g l-1)
1200
800
400
0
Soya F.
 * (3479) Soya F.
 * (1439) W. lactose F.
 * (2720) HA F.
 * (2649) HA F.
 
 
33 
 
0
2
4
6
8
10
12
14
16
18
20
PT
W
I 
(%
)
0-2 weeks 3-4 weeks 2 month 3 month 4-5 month 6 month >7 month
Age
Follow up F.  Non adap. S. F. Adapted S. F. W. lactose F. HA F. Diet F. Soya F.
 
 
 
34 
 
 
0,0
0,5
1,0
1,5
2,0
2,5
3,0
W
ee
kl
y 
in
ta
ke
 (
m
g)
2,0 – 2,5 2,5 – 3,0 3,0 – 3,5 3,5 – 4,0 4,0 – 5,0
Weight  (kg)
Human milk (lower limit)
Spanish human milk
Human milk (upper limit)
Premature Formula
 
 
 
35 
y = -0.0046x + 11.274
p = 0.044
0
2
4
6
8
10
12
14
0 200 400 600 800 1000
Al ( g l -1 )
Fe (mg l -1 )
 
 
 
36 
 
y = -0.0029x + 4.7799
p = 0.004
0
2
4
6
8
0 200 400 600 800 1000
Al ( g l -1 )
Zn (mg l -1 )
 
 
 
37 
Figure 1. Aluminium distributions in infant formulae provided by different manufacturers 
(µg l-1) 
Figure 2. Percentages of PTWI for aluminium estimated from infant formulae. 
Figure 3. Weekly dietary aluminium intake for infant fed on premature infant formulae 
and human milk (mg week-1). 
Figure 4. Iron versus aluminium in follow-up infant formulae. 
Figure 5. Zinc versus aluminium in standard infant formulae (starter and follow-up 
formulae). 
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